Lifeway Foods (LWAY)


Market Price (9/6/2026): $25.01 | Market Cap: $379.2 MilSector: Consumer Staples | Industry: Packaged Foods & Meats

Lifeway Foods (LWAY)


Market Price (9/6/2026): $25.01
Market Cap: $379.2 Mil
Sector: Consumer Staples
Industry: Packaged Foods & Meats

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 26%

Low stock price volatility
Vol 12M is 48%

Megatrend and thematic drivers
Megatrends include Health & Wellness Trends. Themes include Functional Foods & Beverages, and Organic & Natural Products.

Weak multi-year price returns
2Y Excs Rtn is -6.3%

Expensive valuation multiples
P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 34x

Not cash flow generative
FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -13%

Key risks
LWAY key risks include [1] significant governance scrutiny and internal disputes related to a prolonged proxy battle with the founding family and [2] a contentious takeover fight with major shareholder Danone.

0 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 26%
1 Low stock price volatility
Vol 12M is 48%
2 Megatrend and thematic drivers
Megatrends include Health & Wellness Trends. Themes include Functional Foods & Beverages, and Organic & Natural Products.
3 Weak multi-year price returns
2Y Excs Rtn is -6.3%
4 Expensive valuation multiples
P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 34x
5 Not cash flow generative
FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -13%
6 Key risks
LWAY key risks include [1] significant governance scrutiny and internal disputes related to a prolonged proxy battle with the founding family and [2] a contentious takeover fight with major shareholder Danone.

LWAY in ETFs

Weight = LWAY's share of each fund

VTI0.00%
IWM0.00%
IWO0.01%
DFAS0.01%
VTWO0.01%
DFAC0.00%

Valuation & Metrics

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Updated on 9/1/2026

Lifeway Foods (LWAY) stock has gained about 5% since 5/31/2026 because of the following key factors:

1. Lifeway Foods achieved record net sales for fiscal Q2 2026, which ended on June 30, 2026, reaching $66.9 million, a 24.1% increase year-over-year. This marked the company's 27th consecutive quarter of year-over-year net sales growth, with first-half 2026 net sales also hitting a record $129.9 million, up 29.9% year-over-year.

2. The robust sales growth was primarily driven by higher volumes of the company's flagship Lifeway Kefir and high-protein Lifeway Farmer Cheese products. This performance capitalized on strong consumer trends towards protein and digestive health, indicating sustained demand for Lifeway's core offerings.

Show more
Updated on 9/1/2026

Lifeway Foods (LWAY) stock has gained about 5% since 5/31/2026 because of the following key factors:

1. Lifeway Foods achieved record net sales for fiscal Q2 2026, which ended on June 30, 2026, reaching $66.9 million, a 24.1% increase year-over-year. This marked the company's 27th consecutive quarter of year-over-year net sales growth, with first-half 2026 net sales also hitting a record $129.9 million, up 29.9% year-over-year.

2. The robust sales growth was primarily driven by higher volumes of the company's flagship Lifeway Kefir and high-protein Lifeway Farmer Cheese products. This performance capitalized on strong consumer trends towards protein and digestive health, indicating sustained demand for Lifeway's core offerings.

3. Lifeway Foods received positive analyst sentiment, including upgrades to "strong-buy" ratings from BTIG Research on August 21, 2026, and Freedom Capital on August 14, 2026. The consensus rating for the stock is "Buy," with an average price target of $34.00, suggesting a significant potential upside for investors.

4. The company is making strategic investments in its manufacturing capabilities, with a $50.5 million project to expand and modernize its Waukesha, Wisconsin plant. This expansion is expected to double manufacturing capacity and enhance packaging efficiency by early 2027, signaling future operational improvements and growth potential.

Show less
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

The 5.0% change in LWAY stock from 5/31/2026 to 9/5/2026 was primarily driven by a 43.8% change in the company's P/E Multiple.
(LTM values as of)53120269052026Change
Stock Price ($)23.8325.015.0%
Change Contribution By: 
Total Revenues ($ Mil)2292425.7%
Net Income Margin (%)6.5%4.5%-31.4%
P/E Multiple24.234.943.8%
Shares Outstanding (Mil)15150.6%
Cumulative Contribution5.0%

LTM = Last Twelve Months as of date shown

Market Drivers

5/31/2026 to 9/5/2026
ReturnCorrelation
LWAY5.0% 
Market (SPY)1.8%-20.9%
Sector (XLP)2.0%13.1%

Fundamental Drivers

The 12.9% change in LWAY stock from 2/28/2026 to 9/5/2026 was primarily driven by a 18.8% change in the company's Total Revenues ($ Mil).
(LTM values as of)22820269052026Change
Stock Price ($)22.1625.0112.9%
Change Contribution By: 
Total Revenues ($ Mil)20424218.8%
Net Income Margin (%)5.5%4.5%-18.0%
P/E Multiple30.234.915.3%
Shares Outstanding (Mil)15150.4%
Cumulative Contribution12.9%

LTM = Last Twelve Months as of date shown

Market Drivers

2/28/2026 to 9/5/2026
ReturnCorrelation
LWAY12.9% 
Market (SPY)12.6%7.4%
Sector (XLP)-5.5%14.9%

Fundamental Drivers

The -17.9% change in LWAY stock from 8/31/2025 to 9/5/2026 was primarily driven by a -20.2% change in the company's P/E Multiple.
(LTM values as of)83120259052026Change
Stock Price ($)30.4725.01-17.9%
Change Contribution By: 
Total Revenues ($ Mil)19324225.6%
Net Income Margin (%)5.5%4.5%-18.4%
P/E Multiple43.734.9-20.2%
Shares Outstanding (Mil)15150.3%
Cumulative Contribution-17.9%

LTM = Last Twelve Months as of date shown

Market Drivers

8/31/2025 to 9/5/2026
ReturnCorrelation
LWAY-17.9% 
Market (SPY)20.4%8.9%
Sector (XLP)6.9%16.4%

Fundamental Drivers

The 132.7% change in LWAY stock from 8/31/2023 to 9/5/2026 was primarily driven by a 60.4% change in the company's Total Revenues ($ Mil).
(LTM values as of)83120239052026Change
Stock Price ($)10.7525.01132.7%
Change Contribution By: 
Total Revenues ($ Mil)15124260.4%
Net Income Margin (%)3.8%4.5%19.2%
P/E Multiple27.834.925.3%
Shares Outstanding (Mil)1515-2.9%
Cumulative Contribution132.7%

LTM = Last Twelve Months as of date shown

Market Drivers

8/31/2023 to 9/5/2026
ReturnCorrelation
LWAY132.7% 
Market (SPY)77.1%15.8%
Sector (XLP)25.2%11.3%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
LWAY Return-15%21%142%85%-2%6%374%
Peers Return13%-24%-10%-23%-32%-10%-64%
S&P 500 Return27%-19%24%23%16%13%106%

Monthly Win Rates [3]
LWAY Win Rate33%58%50%50%42%33% 
Peers Win Rate56%40%52%40%44%44% 
S&P 500 Win Rate75%42%67%75%67%56% 

Max Drawdowns [4]
LWAY Max Drawdown-35%-46%-30%-60%-36%-27% 
Peers Max Drawdown-22%-41%-38%-32%-43%-34% 
S&P 500 Max Drawdown-5%-25%-10%-8%-19%-9% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: HAIN, BGS, KHC, PEP.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 9/4/2026 (YTD)

How Low Can It Go

EventLWAYS&P 500
2020 COVID-19 Crash
  % Loss-41.0%-33.7%
  % Gain to Breakeven69.4%50.9%
  Time to Breakeven37 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-31.6%-19.2%
  % Gain to Breakeven46.3%23.8%
  Time to Breakeven169 days105 days
2016-2017 Trump Reflation Bond Selloff
  % Loss-43.0%-3.7%
  % Gain to Breakeven75.3%3.9%
  Time to Breakeven2362 days6 days
2015-2016 China Devaluation / Global Growth Scare
  % Loss-31.7%-12.2%
  % Gain to Breakeven46.4%13.9%
  Time to Breakeven310 days62 days
2014-2016 Oil Price Collapse
  % Loss-27.3%-6.8%
  % Gain to Breakeven37.6%7.3%
  Time to Breakeven308 days15 days
2010 Eurozone Sovereign Debt Crisis / Flash Crash
  % Loss-12.9%-15.4%
  % Gain to Breakeven14.8%18.2%
  Time to Breakeven48 days125 days

Compare to HAIN, BGS, KHC, PEP, DOLE

In The Past

Lifeway Foods's stock fell -9.7% during the 2025 US Tariff Shock. Such a loss loss requires a 10.7% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

EventLWAYS&P 500
2020 COVID-19 Crash
  % Loss-41.0%-33.7%
  % Gain to Breakeven69.4%50.9%
  Time to Breakeven37 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-31.6%-19.2%
  % Gain to Breakeven46.3%23.8%
  Time to Breakeven169 days105 days
2016-2017 Trump Reflation Bond Selloff
  % Loss-43.0%-3.7%
  % Gain to Breakeven75.3%3.9%
  Time to Breakeven2362 days6 days
2015-2016 China Devaluation / Global Growth Scare
  % Loss-31.7%-12.2%
  % Gain to Breakeven46.4%13.9%
  Time to Breakeven310 days62 days
2014-2016 Oil Price Collapse
  % Loss-27.3%-6.8%
  % Gain to Breakeven37.6%7.3%
  Time to Breakeven308 days15 days
2008-2009 Global Financial Crisis
  % Loss-52.7%-53.4%
  % Gain to Breakeven111.6%114.4%
  Time to Breakeven198 days1085 days

Compare to HAIN, BGS, KHC, PEP, DOLE

In The Past

Lifeway Foods's stock fell -9.7% during the 2025 US Tariff Shock. Such a loss loss requires a 10.7% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Lifeway Foods (LWAY)

```html

Lifeway Foods, Inc. (LWAY) is a food company focused on producing and marketing probiotic-based products. Its flagship offering is drinkable kefir, a cultured dairy beverage. This primary product comes in a wide variety of options, including organic and non-organic versions, different fat levels such as low-fat, non-fat, and whole milk, and specialized types like protein-enhanced and BioKefir. These are available in various sizes and flavors to cater to diverse consumer preferences.

Beyond its core drinkable kefir line, Lifeway Foods diversifies its product portfolio with several other dairy-based items. This includes European-style soft cheeses, cream products, and a range of specifically targeted offerings like ProBugs, which is kefir designed for children. The company also provides different formats such as cupped kefir, Icelandic Skyr (a strained kefir and yogurt product), and frozen kefir available in both soft serve and pint-size containers.

Lifeway Foods distributes its comprehensive product range under its own Lifeway and Fresh Made brand names, and additionally produces private label goods for other customers. The company primarily sells its products through a direct sales force, brokers, and distributors, serving a broad market across the United States and internationally.

```

AI Analysis | Feedback

Here are 1-3 brief analogies for Lifeway Foods (LWAY):

  • Like the Chobani or Fage of kefir.
  • A smaller Dannon (Danone), but specializing in probiotic kefir.

AI Analysis | Feedback

  • Drinkable Kefir: A cultured dairy product offered in various organic and non-organic sizes, flavors, and types, including low fat, non-fat, whole milk, protein, and BioKefir.
  • European-Style Soft Cheeses: A line of soft cheeses made in the European tradition.
  • Cream: Dairy cream products.
  • ProBugs: A specific line of kefir products tailored for children.
  • Cupped Kefir and Icelandic Skyr: Strained kefir and yogurt products available in single-serving cups.
  • Frozen Kefir: Kefir products offered in both soft-serve and pint-size frozen formats.

AI Analysis | Feedback

null

AI Analysis | Feedback

null

AI Analysis | Feedback

Lifeway Foods (LWAY) Management Team:

Julie Smolyansky

President, Chief Executive Officer, Secretary and Director

Julie Smolyansky became the youngest female CEO of a publicly held firm when she took over Lifeway Foods at the age of 27 in 2002, following the passing of her father, Michael Smolyansky, who founded the company in 1986. Under her leadership, Lifeway's annual revenue has grown significantly, from $12 million in 2002 to a projected $185-$186.5 million in 2024, and reached $210 million in 2025. She has expanded the company's distribution across the United States, Mexico, France, Ireland, and parts of Central and South America and the Caribbean. Smolyansky is also a co-founder of Test400k, a non-profit dedicated to ending the backlog of untested rape kits in the U.S.

Eric Hanson

Chief Financial and Accounting Officer and Treasurer

Eric Hanson is Lifeway's Chief Financial and Accounting Officer and Treasurer. He joined Lifeway as Controller in July 2016 and was promoted to Chief Accounting Officer in May 2018. Prior to Lifeway, Eric was Director of External Reporting for CPG International from 2014 through 2016 and an Audit Manager for Deloitte and Touche from 2012 to 2014. He also held various audit positions with Crowe Horwath from 2003 through 2012, bringing over 20 years of accounting and financial reporting experience. He holds a Bachelor of Science in Finance from the University of Illinois.

Joe Walker

Executive Vice President and Chief Operating Officer

Joe Walker is the Executive Vice President and Chief Operating Officer of Lifeway. He previously served as Chief Financial Officer for seven years and has held various financial positions at Lifeway since 1986. He oversees all areas of operations and works with the executive leadership team. Walker is a CPA and holds a bachelor's degree with a major in accounting from the University of Tennessee, Martin.

Amy Feldman

Senior Executive Vice President of Sales

Amy Feldman was appointed Lifeway's Senior Executive Vice President of Sales in October 2018. She has over 20 years of experience in the food industry, focusing on building businesses, brands, and teams, particularly in the Fresh and Natural Foods sector. Her background includes experience as a retailer, broker, distributor, and working with high-growth food brands across various sales channels.

Ludmila Smolyansky

Chairperson of the Board

Ludmila Smolyansky co-founded Lifeway Foods in 1986 with her husband, Michael Smolyansky. They immigrated to the U.S. from the Soviet Union in 1976. After discovering kefir at a German food show in 1985, they were inspired to produce it in the United States, starting the company with an initial capital of $250,000. She currently serves as the Chairperson of the Board.

AI Analysis | Feedback

The key risks to Lifeway Foods (LWAY) are:
  1. Corporate Governance Issues and Internal Disputes: Lifeway Foods faces significant governance scrutiny, particularly regarding the CEO's spouse's role, executive compensation practices, and a prolonged proxy battle involving members of the founding family. The company has also been engaged in a contentious battle against a potential takeover by French dairy giant Danone, a major shareholder, with accusations that Danone has attempted to undermine Lifeway's business and control. This internal discord and external pressure from a large shareholder could lead to management distraction, instability, and impact strategic decision-making and investor confidence.
  2. Intense Market Competition: The cultured dairy and functional food sectors in which Lifeway operates are highly competitive. Lifeway faces strong competition from larger consumer packaged goods (CPG) companies such as Danone, General Mills, and Chobani, which possess extensive marketing budgets and distribution capabilities. This intense competition can challenge Lifeway's market share and pricing power.
  3. Volatility in Raw Material Prices: As a producer of dairy-based products, Lifeway Foods is susceptible to significant fluctuations in the prices of raw materials, particularly milk. Volatile commodity prices can directly impact the company's cost of goods sold, subsequently affecting its profitability and financial performance.

AI Analysis | Feedback

The rapid and increasing consumer shift towards plant-based diets and alternatives, including fermented plant-based beverages, poses a threat to Lifeway Foods, whose primary products are dairy-based. As consumers seek non-dairy options for health, ethical, or environmental reasons, the market for traditional dairy kefir may shrink or grow more slowly than the plant-based segment, potentially eroding Lifeway's market share or growth opportunities if they do not adequately diversify their product offerings.

AI Analysis | Feedback

Lifeway Foods (LWAY) operates within several addressable markets related to probiotic-based dairy products, including kefir, Icelandic Skyr, soft cheeses, and cream products. These markets show significant growth potential, particularly in the United States and globally.

Kefir Products (Drinkable, Cupped, ProBugs, Frozen Kefir)

  • The global kefir market was valued at approximately USD 2.16 billion in 2024 and is projected to reach about USD 3.68 billion by 2033.
  • In North America, the kefir market was valued at USD 275.61 million in 2024 and is expected to reach USD 435.32 million by 2033. The U.S. kefir market alone is projected to reach USD 296.13 million by 2032.
  • More broadly, the U.S. yogurt and probiotic drink market was estimated at USD 8.43 billion in 2022 and is expected to continue growing through 2030. The global probiotic drinks market was valued at USD 24.85 billion in 2024 and is projected to grow to approximately USD 56.19 billion by 2034. North America was the dominant region in the probiotic drinks market in 2024.

Icelandic Skyr

  • The global Skyr yogurt market size was valued at USD 2.1 billion in 2024 and is anticipated to reach USD 4.2 billion by 2033.
  • North America represents a fast-growing regional market for Skyr yogurt, with sales reaching USD 650 million in 2024. Skyr is also a component of the broader U.S. yogurt market, which was estimated at USD 12.87 billion in 2026 and is projected to reach USD 16.08 billion by 2031.

European-Style Soft Cheeses

  • The global soft cheese market was valued at USD 10.57 billion by the end of 2025 and is projected to reach USD 15.50 billion by 2033.
  • North America accounts for approximately 28.25% of the global soft cheese market revenue in 2025. The U.S. cheese market overall is forecast to increase by USD 12.2 billion between 2024 and 2029.

Cream and Other Products

  • The U.S. cream cheese market was valued at USD 5.8 billion in 2024 and is estimated to reach USD 12.6 billion by 2034.
  • The broader U.S. dairy products market, which encompasses cream and other dairy items, was valued at USD 120.7 billion in 2024 and is projected to reach USD 167.9 billion by 2032.

AI Analysis | Feedback

Lifeway Foods (LWAY) is expected to drive future revenue growth over the next 2-3 years through several key initiatives and market trends:

  1. Sustained Volume-Led Growth of Core Kefir Products: Lifeway Foods anticipates continued strong performance from its flagship Lifeway branded drinkable kefir. The company has consistently reported double-digit volume-led growth in this category, with 21 consecutive quarters of year-over-year net sales growth by the end of 2024, and continued strong volume-led growth into 2025.
  2. Expansion of Product Portfolio and Innovation: The company is actively diversifying its product offerings beyond traditional kefir. This includes the launch of new products such as kefir butter (expected in 2026), Muscle Mates, and collagen smoothies. Lifeway aims to generate 30% of its revenue from non-traditional products by the end of 2026.
  3. Increased Manufacturing Capacity: To support growing demand, Lifeway is investing in expanding its production capabilities. The Waukesha facility expansion is slated to double capacity by the end of 2026 and significantly increase bottling speeds.
  4. Strategic Sales and Marketing Investments: Lifeway plans to continue investing in sales and marketing initiatives to drive product trial, accelerate product velocities, and attract new customers. These efforts leverage the increasing consumer demand for health and wellness products, particularly those offering probiotics, high protein, and functional benefits. The company is also focusing on distribution by expanding products like its Lifeway Farmer Cheese line into major retail channels.
  5. Market Expansion through International Growth and Strategic Acquisitions: Lifeway Foods is pursuing growth in new markets. Its international expansion strategy targets a 25% year-over-year sales increase in the EMEA and APAC regions. Additionally, the company is open to strategic acquisitions, having recently acquired a plant-based yogurt maker and aiming to evaluate 3-5 acquisition targets annually through 2027 to further diversify its portfolio.

AI Analysis | Feedback

Share Repurchases

  • On June 28, 2025, Lifeway Foods' Board of Directors approved a new share repurchase program authorizing the company to repurchase up to 250,000 shares within a two-year period.
  • This share repurchase program is intended to be funded using available cash generated through operations.
  • No purchases of equity securities by the issuer were reported in fiscal years 2024 or 2023.

Share Issuance

  • As of April 25, 2025, and March 14, 2025, Lifeway Foods had 15,203,241 shares of common stock outstanding.
  • On March 20, 2023, the company reported 14,644,762 shares of common stock outstanding.
  • As of December 31, 2022, shares outstanding were approximately 16 million.

Inbound Investments

  • A Cooperation Agreement with Danone was detailed in an 8-K filing on September 30, 2025, which includes provisions for board refreshment, voting commitments, and registration rights for Danone's holdings.
  • Lifeway Foods has 119 institutional owners and shareholders, including firms like Divisadero Street Capital Management, Cresset Asset Management, Renaissance Technologies, Vanguard Group, and BlackRock, holding a total of 4,956,013 shares.

Outbound Investments

  • In August 2021, Lifeway Foods acquired the Glen Oaks Farms drinkable yogurt product line.

Capital Expenditures

  • Lifeway Foods reported capital expenditures of $10.9 million for September 2025 and $5.1 million in Q3 2025.
  • Annual capital expenditures were $6.7 million for fiscal year 2024.
  • Year-to-date capital expenditures for 2025 were $9 million, primarily allocated to the expansion of its Waukesha facility to double capacity by the end of 2026 and triple bottling speeds.

Better Bets vs. Lifeway Foods (LWAY)

Peer Outperformance in Packaged Foods & Meats

LWAY has outperformed 98% of its 46 Packaged Foods & Meats peers over 5Y. Packaged Foods & Meats ranks 10th of 12 industries in Consumer Staples by median 5Y return. The sector’s gains have largely come from elsewhere.
Share of Packaged Foods & Meats constituents that LWAY has outperformed, by holding period. Peers without a full price history over a given window are excluded from that window.
1Y
56%
of 52 industry peers · -19.6% return
3Y
90%
of 50 industry peers · 116.9% return
5Y
98%
of 46 industry peers · 363.1% return
No Packaged Foods & Meats peer with a comparable growth profile has beaten LWAY by more than 20pp over 5Y.
Median price return by industry across the Consumer Staples sector, ranked by 5Y. Packaged Foods & Meats is LWAY's own industry. Use this to see which corners of the sector have carried the returns.
Industry Names 1Y med3Y med5Y med Top 3 by 5Y
Consumer Staples Merchandise Retail 12 13.1%45.6%49.5% NGVC 179% · VLGEA 135% · WMT 129%
Tobacco 6 -26.6%18.6%35.8% PM 117% · MO 99% · TPB 50%
Food Retail 6 -11.6%73.8%30.0% CASY 276% · SFM 232% · KR 40%
Food Distributors 9 -0.2%40.9%18.1% CHEF 294% · USFD 214% · ANDE 151%
Soft Drinks & Non-alcoholic Beverages 12 -6.5%-12.2%5.3% COKE 398% · BRFH 202% · CCHGY 109%
Brewers 3 -16.0%-27.3%1.7% BUD 44% · TAP 2% · SAM -70%
Agricultural Products & Services 11 3.8%6.6%-11.5% BG 75% · ADM 62% · INGR 32%
Household Products 19 0.6%-6.1%-23.3% IPAR 76% · ACU 69% · CL 28%
Personal Care Products 4 -5.8%-18.0%-25.8% ELF 258% · PG 16% · EL -67%
Packaged Foods & Meats ← 47 -23.5%-31.3%-39.5% MAMA 466% · LWAY 363% · SENEA 302%
Distillers & Vintners 5 -42.3%-58.4%-74.9% STZ -34% · BF-B -58% · MGPI -75%
Drug Retail 3 -40.7%-83.9%-92.7% HITI -66% · PETS -93% · SCNX -99%
Median of constituents with a full price history over each window. Top names are unfiltered by size in this render.

Latest Trefis Analyses

Title
0ARTICLES

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

LWAYHAINBGSKHCPEPMedian
NameLifeway .Hain Cel.B&G FoodsKraft He.PepsiCo  
Mkt Price25.010.753.2924.85137.6324.85
Mkt Cap0.40.10.329.5188.00.4
Rev LTM2421,4541,77124,90096,9041,771
Op Inc LTM16271734,22814,495173
FCF LTM-3142643,8169,28264
FCF 3Y Avg-5551073,4097,793107
CFO LTM1164894,62113,45689
CFO 3Y Avg13821354,37512,794135

Growth & Margins

LWAYHAINBGSKHCPEPMedian
NameLifeway .Hain Cel.B&G FoodsKraft He.PepsiCo  
Rev Chg LTM25.6%-10.0%-4.9%-1.6%5.6%-1.6%
Rev Chg 3Y Avg17.3%-6.9%-6.0%-2.8%2.5%-2.8%
Rev Chg Q24.1%-13.3%-9.7%-1.4%6.4%-1.4%
QoQ Delta Rev Chg LTM5.7%-3.5%-2.3%-0.4%1.5%-0.4%
Op Inc Chg LTM28.2%-63.5%-6.5%-18.1%17.0%-6.5%
Op Inc Chg 3Y Avg33.7%-22.4%-9.2%-4.1%6.9%-4.1%
Op Mgn LTM6.5%1.9%9.8%17.0%15.0%9.8%
Op Mgn 3Y Avg8.0%3.9%10.3%19.2%14.3%10.3%
QoQ Delta Op Mgn LTM-2.6%-0.8%0.2%-1.4%0.2%-0.8%
CFO/Rev LTM4.6%4.4%5.0%18.6%13.9%5.0%
CFO/Rev 3Y Avg6.7%5.0%7.1%17.2%13.7%7.1%
FCF/Rev LTM-12.8%2.9%3.6%15.3%9.6%3.6%
FCF/Rev 3Y Avg-1.5%3.3%5.7%13.4%8.3%5.7%

Valuation

LWAYHAINBGSKHCPEPMedian
NameLifeway .Hain Cel.B&G FoodsKraft He.PepsiCo  
Mkt Cap0.40.10.329.5188.00.4
P/S1.60.00.21.21.91.2
P/Op Inc24.12.51.57.013.07.0
P/EBIT24.0-0.23.96.813.26.8
P/E34.9-0.1-3.8-8.718.0-0.1
P/CFO33.81.13.06.414.06.4
Total Yield2.9%-755.5%-3.7%-5.1%9.7%-3.7%
Dividend Yield0.0%0.0%22.8%6.4%4.2%4.2%
FCF Yield 3Y Avg0.2%40.9%25.8%10.8%4.0%10.8%
D/E0.18.79.60.60.30.6
Net D/E0.08.17.40.60.20.6

Returns

LWAYHAINBGSKHCPEPMedian
NameLifeway .Hain Cel.B&G FoodsKraft He.PepsiCo  
1M Rtn-19.5%26.3%-3.8%1.2%0.5%0.5%
3M Rtn6.0%2.5%-13.6%11.8%-2.0%2.5%
6M Rtn17.7%9.8%-36.0%4.7%-11.8%4.7%
12M Rtn-19.6%-58.9%-18.4%-2.7%-2.2%-18.4%
3Y Rtn116.9%-92.3%-60.8%-9.8%-12.2%-12.2%
1M Excs Rtn-19.6%26.2%-3.9%1.0%0.4%0.4%
3M Excs Rtn1.4%-2.0%-18.2%7.3%-6.5%-2.0%
6M Excs Rtn3.2%-4.7%-50.6%-9.8%-26.4%-9.8%
12M Excs Rtn-37.8%-78.5%-36.7%-20.2%-20.3%-36.7%
3Y Excs Rtn62.8%-164.1%-134.9%-82.7%-85.7%-85.7%

Comparison Analyses

null

Financials

Segment Financials

Revenue by Segment
$ Mil20252024202320222021
Drinkable Kefir other than ProBugs18115312811096
Cheese1715141313
Cream and other98774
Drinkable Yogurt26662
ProBugs Kefir23333
Other dairy11222
Total212187160142119


Operating Income by Segment
$ Mil199719961995
Dairy Products111
Restaurant 0 
Corporate & Other  -0
Total110


Assets by Segment
$ Mil199719961995
Dairy Products653
Corporate & Other000
Restaurant001
Total654


Price Behavior

Price Behavior
Market Price$25.01 
Market Cap ($ Bil)0.4 
First Trading Date08/18/1995 
Distance from 52W High-26.0% 
   50 Days200 Days
DMA Price$28.95$24.69
DMA Trendupup
Distance from DMA-13.6%1.3%
 3M1YR
Volatility51.7%48.1%
Downside Capture-136.8513.70
Upside Capture-81.93-14.61
Correlation (SPY)-21.2%8.4%
LWAY Betas & Captures as of 8/31/2026

 1M2M3M6M1Y3Y
Beta-2.02-1.38-0.820.290.350.76
Up Beta-0.56-1.090.281.101.201.07
Down Beta-3.31-0.75-0.720.040.350.31
Up Capture-285%-164%-82%16%-6%63%
Bmk +ve Days10213268138427
Stock +ve Days10223762122363
Down Capture-207%-147%-197%-21%15%86%
Bmk -ve Days11213259113324
Stock -ve Days11202763127377

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with LWAY
LWAY-19.1%48.0%-0.28-
Sector ETF (XLP)7.1%14.4%0.2516.5%
Equity (SPY)19.7%12.8%1.138.6%
Gold (GLD)24.6%29.2%0.756.4%
Commodities (DBC)43.8%20.3%1.67-12.7%
Real Estate (VNQ)9.1%13.6%0.3916.6%
Bitcoin (BTCUSD)-28.1%43.8%-0.633.0%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with LWAY
LWAY36.0%66.6%0.73-
Sector ETF (XLP)6.0%13.7%0.2211.6%
Equity (SPY)12.8%17.2%0.5718.6%
Gold (GLD)19.1%18.8%0.824.6%
Commodities (DBC)10.7%19.5%0.43-2.8%
Real Estate (VNQ)1.7%18.9%-0.0116.1%
Bitcoin (BTCUSD)10.2%52.6%0.389.8%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with LWAY
LWAY8.6%68.7%0.41-
Sector ETF (XLP)7.2%14.9%0.359.7%
Equity (SPY)15.3%17.9%0.7216.4%
Gold (GLD)12.4%16.3%0.624.4%
Commodities (DBC)7.9%18.1%0.354.5%
Real Estate (VNQ)4.8%20.7%0.1914.1%
Bitcoin (BTCUSD)63.7%66.2%1.037.9%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date8142026
Short Interest: Shares Quantity0.4 Mil
Short Interest: % Change Since 731202620.1%
Average Daily Volume0.2 Mil
Days-to-Cover Short Interest2.0 days
Basic Shares Quantity15.2 Mil
Short % of Basic Shares2.4%

Earnings Returns History

Updated 8/24/2026
Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
8/13/2026-15.5%-14.3% 
5/14/2026-4.6%-6.3%-8.0%
3/17/2026-7.2%-9.7%18.7%
1/8/20260.4%-2.4%-4.3%
11/12/2025-2.5%-6.8%-0.9%
8/12/20256.8%10.5%16.9%
3/5/2025-1.2%-2.6%16.9%
1/6/2025-3.3%-7.7%-6.0%
SUMMARY STATS   
# Positive213
# Negative674
Median Positive3.6%10.5%16.9%
Median Negative-3.9%-6.8%-5.1%
Max Positive6.8%10.5%18.7%
Max Negative-15.5%-14.3%-8.0%
Collapse to Preview
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
8/13/2026-15.5%-14.3% 
5/14/2026-4.6%-6.3%-8.0%
3/17/2026-7.2%-9.7%18.7%
1/8/20260.4%-2.4%-4.3%
11/12/2025-2.5%-6.8%-0.9%
8/12/20256.8%10.5%16.9%
3/5/2025-1.2%-2.6%16.9%
1/6/2025-3.3%-7.7%-6.0%
SUMMARY STATS   
# Positive213
# Negative674
Median Positive3.6%10.5%16.9%
Median Negative-3.9%-6.8%-5.1%
Max Positive6.8%10.5%18.7%
Max Negative-15.5%-14.3%-8.0%

SEC Filings

Expand for More
Report DateFiling DateFiling
06/30/202608/13/202610-Q
03/31/202605/14/202610-Q
12/31/202503/17/202610-K
09/30/202511/12/202510-Q
06/30/202508/12/202510-Q
03/31/202505/13/202510-Q
12/31/202403/14/202510-K
09/30/202411/14/202410-Q
06/30/202408/13/202410-Q
03/31/202405/14/202410-Q
12/31/202303/20/202410-K
09/30/202311/13/202310-Q
06/30/202308/14/202310-Q
03/31/202305/15/202310-Q
12/31/202203/27/202310-K
09/30/202211/14/202210-Q
Collapse to Preview
Report DateFiling DateFiling
06/30/202608/13/202610-Q
03/31/202605/14/202610-Q
12/31/202503/17/202610-K
09/30/202511/12/202510-Q
06/30/202508/12/202510-Q
03/31/202505/13/202510-Q
12/31/202403/14/202510-K
09/30/202411/14/202410-Q
06/30/202408/13/202410-Q
03/31/202405/14/202410-Q
12/31/202303/20/202410-K
09/30/202311/13/202310-Q
06/30/202308/14/202310-Q
03/31/202305/15/202310-Q
12/31/202203/27/202310-K
09/30/202211/14/202210-Q
06/30/202209/26/202210-Q
03/31/202208/26/202210-Q
12/31/202107/21/202210-K
09/30/202111/15/202110-Q
06/30/202108/16/202110-Q
03/31/202105/17/202110-Q
12/31/202003/25/202110-K
09/30/202011/16/202010-Q
06/30/202008/13/202010-Q
03/31/202006/26/202010-Q
12/31/201904/14/202010-K
09/30/201911/14/201910-Q

Recent Forward Guidance

Updated 8/14/2026

Latest: Q2 2026 Earnings Reported 8/13/2026

Forward GuidanceGuidance Change
MetricSourceLowMidHigh% Chg% DeltaChangePrior
2027 Gross MarginReported      


Prior: Q1 2026 Earnings Reported 5/14/2026

Forward GuidanceGuidance Change
MetricSourceLowMidHigh% Chg% DeltaChangePrior
2027 Adjusted EBITDAReported45.00 Mil47.50 Mil50.00 Mil0 AffirmedGuidance: 47.50 Mil for 2027

Insider Activity

Updated 9/2/2026
Expand for More
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Smolyansky, JulieCEO, President and SecretaryDirectBuy819202625.262,00050,52055,928,040Form
2Divisadero, Street Capital Management, LPSee footnoteBuy817202624.7835,952890,92358,188,230Form
3Divisadero, Street Capital Management, LPSee footnoteBuy817202624.6915,000370,35257,087,363Form
4Divisadero, Street Capital Management, LPSee footnoteBuy817202624.87195,6164,865,53757,136,931Form
5Smolyansky, EdwardSee footnoteSell814202625.4575,0001,908,68522,771,709Form
Collapse to Preview
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Smolyansky, JulieCEO, President and SecretaryDirectBuy819202625.262,00050,52055,928,040Form
2Divisadero, Street Capital Management, LPSee footnoteBuy817202624.7835,952890,92358,188,230Form
3Divisadero, Street Capital Management, LPSee footnoteBuy817202624.6915,000370,35257,087,363Form
4Divisadero, Street Capital Management, LPSee footnoteBuy817202624.87195,6164,865,53757,136,931Form
5Smolyansky, EdwardSee footnoteSell814202625.4575,0001,908,68522,771,709Form
6Smolyansky, EdwardSee footnoteSell814202628.7435,0001,005,90027,871,851Form
7Smolyansky, LudmilaSee footnoteSell723202630.11100,0003,011,40015,274,032Form
8Smolyansky, EdwardSee footnoteSell716202632.0266,9162,142,75632,175,062Form
9Smolyansky, EdwardSee footnoteSell709202629.4139,0981,149,87231,518,962Form
10Smolyansky, EdwardSee footnoteSell709202629.797,984237,84333,090,941Form
11Smolyansky, EdwardDirectSell702202629.5650,0001,478,00025,204,098Form
12Smolyansky, EdwardSee FootnoteSell702202630.1214,542438,00535,203,985Form
13Smolyansky, EdwardDirectSell702202629.26111,5483,263,36126,406,991Form
14Smolyansky, LudmilaSee footnoteSell626202629.6545,6161,352,51418,003,688Form
15Smolyansky, LudmilaSee footnoteSell626202630.1240,0001,204,80019,663,029Form
16Smolyansky, EdwardDirectSell626202629.8538,4521,147,89430,276,250Form
17Smolyansky, EdwardSee footnoteSell622202626.2050,0001,310,00031,003,325Form
18Smolyansky, LudmilaSee footnoteSell611202624.0220,000480,40016,641,608Form
19Danone, S.a. DirectSell520202619.503,454,756  Form
20Divisadero, Street Capital Management, LPSee FootnoteBuy518202625.2733,174838,29053,104,865Form
21Smolyansky, EdwardDirectSell518202624.8724,000596,80526,175,917Form
22Divisadero, Street Capital Management, LPSee FootnoteBuy518202625.50131,8713,362,67852,742,821Form
23Smolyansky, EdwardDirectSell518202625.3425,000633,49727,281,999Form
24Smolyansky, LudmilaSee footnoteSell421202626.5015,000397,50019,419,810Form
25Smolyansky, EdwardDirectSell318202620.1022,313448,49122,431,500Form
26Smolyansky, EdwardDirectSell318202620.6013,334274,68023,449,145Form
27Smolyansky, LudmilaSee footnoteSell1229202524.4226,431645,35118,503,344Form
28Smolyansky, LudmilaSee footnoteSell1212202523.1720,000463,40018,171,165Form
29Smolyansky, LudmilaSee footnoteSell1210202523.4113,569317,65018,827,586Form
30Smolyansky, LudmilaSee footnoteSell1210202523.5615,000353,40019,267,910Form
31Smolyansky, LudmilaSee footnoteSell1009202526.4410,000264,40022,019,840Form
32Smolyansky, LudmilaSee footnoteSell1009202526.325,000131,60022,183,101Form
33Smolyansky, EdwardDirectSell1003202525.9183,6432,166,92629,835,406Form
34Smolyansky, EdwardDirectSell925202526.6910,000266,90032,969,757Form
35Smolyansky, EdwardDirectSell925202526.536,357168,65133,037,411Form
Core Cache Last Updated: 9/5/2026